Alzamend Neuro Inc
- ALZN
- NASDAQ
- Biotechnology
- Alzheimer's Disease
- Neurodegenerative Therapies
$1.33
Today +2.31%Quote Oct 19, 2026, 08:00 PM UTC
−30.95%over the last month
Max drawdown −34.0%From 1-month high −32.7%3 months −1.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Alzamend Neuro
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
6
Founded
2016
Market value
$6.4M
Quote Oct 19
Floor
$1.33
0.2% below price
Resistance
$1.36
2.5% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ALZNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free